Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral L-Carnitine in Hemodialysis Patients
NCT07249229Phase 2Completed
- Start
- Nov 2020
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levocarnitine in end stage renal disease (ESRD). Started Nov 2020; status: completed.
02
Drugs
levocarnitine
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT07249229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07249229.